Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
772.56-
QQQ
745.680.24%
BTC/USD
85664.610.6189%
DIA
516.700.25%
GLD
394.811.32%
TLT
81.480.33%

Tenax Therapeutics Inc (TENX) Stock Price, Quote, News & History

TENXNASDAQ
Trade with Public
Trade with Public
$1.91
-0.03-1.55%
Last update: Sep 23, 9:31 AM
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Tenax Therapeutics (TENX) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
-
Close
-
Volume / Avg.
46.88K / 5.28M
Day Range
- - -
52 Wk Range
1.31 - 19.40
Market Cap
$50.66M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
29
Short Interest
35.39%
Days to Cover
1.12

Recent Tenax Therapeutics Inc News

5 Stocks In The Spotlight From Wall Street's Most Accurate Analysts Last Month

U.S. stocks settled lower on Monday, with the Dow Jones index falling more than 350 points during the session. Renewed US-Iran strikes over the weekend sent crude sharply higher Monday, reviving inflation fears and
Avi Kapoor

This Sempra Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Mizuho analyst
Avi Kapoor

Crude Oil Surges 3%; Sionna Therapeutics Shares Plunge

US stocks mixed, Dow Jones down 0.2% midday. Energy shares up 3%, real estate down 1.4%. National Energy Services up 16% on strong earnings.
Avi Kapoor

Tenax Therapeutics Stock Dives as It Faces Heart Drug Study Setback

Tenax Therapeutics announced Phase 3 LEVEL trial results for TNX-103, missing primary endpoints while showing subgroup benefits.
Vandana Singh

US Stocks Edge Lower; Monday.Com Shares Tumble After Q2 Results

Dow Jones fell 0.2% as US stocks opened lower. Energy shares rose 1.9%, while real estate stocks dropped 0.9%. Monday.com shares fell 10%.
Avi Kapoor

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-46.03M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
58.54M
Free Cash Flow (TTM)
-46.03M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
12.51M

Analyst Trends and Forecast

4
Jun
5
Jul
2
3
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$45.37M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.64
Earnings Yield % (TTM)
-76.29%
Earnings Yield % (FWD)
-79.12%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$3.04

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$117.98M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
-
Volume / Avg.
46.88K / 5.28M
Day Range
- - -
52 Wk Range
1.31 - 19.40
Market Cap
$50.66M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
29
Short Interest
35.39%
Days to Cover
1.12

About

Sector
Health Care
Industry
Biotechnology
Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Tenax Therapeutics (TENX) stock?

A

You can purchase shares of Tenax Therapeutics (NASDAQ:TENX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Tenax Therapeutics (TENX) competitors?

Q

What is the forecast, or price target, for Tenax Therapeutics (TENX) stock?

A

Tenax Therapeutics has a consensus price target of $22.50.

Q

What is the current price for Tenax Therapeutics (TENX)?

A

The stock price for Tenax Therapeutics (NASDAQ: TENX) is $1.91 last updated September 23, 2026 at 9:31 AM EDT.

Q

Does Tenax Therapeutics (TENX) pay a dividend?

A

There are no upcoming dividends for Tenax Therapeutics.

Q

When is Tenax Therapeutics (NASDAQ:TENX) reporting earnings?

A

Tenax Therapeutics does not have any upcoming earnings scheduled.

Q

Is Tenax Therapeutics (TENX) going to split?

A

There is no upcoming split for Tenax Therapeutics.

Q

What sector and industry does Tenax Therapeutics (TENX) operate in?

A

Tenax Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved